Miguel Ángel
Hernández Pérez
Professeur Assistant à Temps Partiel (Sciences de la Santé)
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublications en collaboration avec des chercheurs de Icahn School of Medicine at Mount Sinai (1)
2018
-
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415